Patient Lifestyle

In October, Novartis expects to launch Tasigna for the treatment of chronic myeloid leukemia in adults who have developed resistance or intolerance to at least one prior therapy, including imatinib.

Cow's milk protein allergy is the most common form of milk protein allergy, occurring in 2-5% of formula-fed babies and 0.4-0.5% of breastfed babies.

Study examines effects of daily combination of folic acid, vitamin B6 and vitamin B12 on the occurrence of cardiovascular events among women with and without a history of CVD.